These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25529014)

  • 1. Very Late Treatment-Related Alterations in Brain Function of Breast Cancer Survivors.
    Stouten-Kemperman MM; de Ruiter MB; Boogerd W; Veltman DJ; Reneman L; Schagen SB
    J Int Neuropsychol Soc; 2015 Jan; 21(1):50-61. PubMed ID: 25529014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotoxicity in breast cancer survivors ≥10 years post-treatment is dependent on treatment type.
    Stouten-Kemperman MM; de Ruiter MB; Koppelmans V; Boogerd W; Reneman L; Schagen SB
    Brain Imaging Behav; 2015 Jun; 9(2):275-84. PubMed ID: 24858488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
    Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
    J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer.
    de Ruiter MB; Reneman L; Boogerd W; Veltman DJ; van Dam FS; Nederveen AJ; Boven E; Schagen SB
    Hum Brain Mapp; 2011 Aug; 32(8):1206-19. PubMed ID: 20669165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtle hippocampal deformities in breast cancer survivors with reduced episodic memory and self-reported cognitive concerns.
    Apple AC; Ryals AJ; Alpert KI; Wagner LI; Shih PA; Dokucu M; Cella D; Penedo FJ; Voss JL; Wang L
    Neuroimage Clin; 2017; 14():685-691. PubMed ID: 28377882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain Hyperconnectivity >10 Years After Cisplatin-Based Chemotherapy for Testicular Cancer.
    Stouten-Kemperman MM; de Ruiter MB; Boogerd W; Kerst JM; Kirschbaum C; Reneman L; Schagen SB
    Brain Connect; 2018 Sep; 8(7):398-406. PubMed ID: 29999422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive dysfunction and symptom burden in women treated for breast cancer: a prospective behavioral and fMRI analysis.
    Jung MS; Zhang M; Askren MK; Berman MG; Peltier S; Hayes DF; Therrien B; Reuter-Lorenz PA; Cimprich B
    Brain Imaging Behav; 2017 Feb; 11(1):86-97. PubMed ID: 26809289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal MRI and cognitive function in patients with breast cancer prior to adjuvant treatment--the role of fatigue.
    Menning S; de Ruiter MB; Veltman DJ; Koppelmans V; Kirschbaum C; Boogerd W; Reneman L; Schagen SB
    Neuroimage Clin; 2015; 7():547-54. PubMed ID: 25844311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type.
    Menning S; de Ruiter MB; Veltman DJ; Boogerd W; Oldenburg HS; Reneman L; Schagen SB
    PLoS One; 2017; 12(3):e0171724. PubMed ID: 28267750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
    Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
    J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariate pattern analysis of FMRI in breast cancer survivors and healthy women.
    Hosseini SM; Kesler SR
    J Int Neuropsychol Soc; 2014 Apr; 20(4):391-401. PubMed ID: 24135221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging.
    de Ruiter MB; Reneman L; Boogerd W; Veltman DJ; Caan M; Douaud G; Lavini C; Linn SC; Boven E; van Dam FS; Schagen SB
    Hum Brain Mapp; 2012 Dec; 33(12):2971-83. PubMed ID: 22095746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered neural activation during prepotent response inhibition in breast cancer survivors treated with chemotherapy: an fMRI study.
    Kam JW; Boyd LA; Hsu CL; Liu-Ambrose T; Handy TC; Lim HJ; Hayden S; Campbell KL
    Brain Imaging Behav; 2016 Sep; 10(3):840-8. PubMed ID: 26489975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of decision making under ambiguity and decision making under risk in breast cancer patients receiving adjuvant chemotherapy: a neuropsychological study.
    Chen X; Zhu C; Li J; Qiu L; Zhang L; Yu F; Ye R; Zhang J; Wang K
    Brain Res; 2013 Oct; 1533():63-72. PubMed ID: 23954744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study.
    Tager FA; McKinley PS; Schnabel FR; El-Tamer M; Cheung YK; Fang Y; Golden CR; Frosch ME; Habif U; Mulligan MM; Chen IS; Hershman DL
    Breast Cancer Res Treat; 2010 Aug; 123(1):25-34. PubMed ID: 19894112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional MRI studies in non-CNS cancers.
    de Ruiter MB; Schagen SB
    Brain Imaging Behav; 2013 Dec; 7(4):388-408. PubMed ID: 23934234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous Response of Chemotherapy-Related Cognitive Decline in Patients with Breast Cancer: A Prospective Study.
    Schrauwen W; Van de Cavey J; Vingerhoets G; Vanheule S; Van den Broecke R; Denys H
    J Int Neuropsychol Soc; 2020 Sep; 26(8):806-814. PubMed ID: 32312360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late effects of adjuvant chemotherapy for adult onset non-CNS cancer; cognitive impairment, brain structure and risk of dementia.
    Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Schagen SB
    Crit Rev Oncol Hematol; 2013 Oct; 88(1):87-101. PubMed ID: 23768778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy.
    Silverman DH; Dy CJ; Castellon SA; Lai J; Pio BS; Abraham L; Waddell K; Petersen L; Phelps ME; Ganz PA
    Breast Cancer Res Treat; 2007 Jul; 103(3):303-11. PubMed ID: 17009108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of adjuvant treatment on cognitive function in women with early breast cancer.
    Hedayati E; Alinaghizadeh H; Schedin A; Nyman H; Albertsson M
    Eur J Oncol Nurs; 2012 Jul; 16(3):315-22. PubMed ID: 21908235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.